## Background: Expression of thymidylate synthase (ts) has been studied as a mechanism of drug resistance and a prognostic factor for various cancers. ## Methods: The relation between ts expression in surgically resected specimens and patient survival was examined in 86 patients with colorectal c
Prognostic significance of thymidylate synthase activity in bladder carcinoma
โ Scribed by Yoichi Mizutani; Hiromi Wada; Osamu Ogawa; Osamu Yoshida; Masakazu Fukushima; Norio Nonomura; Tsuneharu Miki
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 143 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
5-fluorouracil (5-fu) is an anticancer agent clinically used against various cancers including bladder carcinoma. 5-fu inhibits thymidylate synthase (ts) and blocks dna synthesis. ts is the key enzyme in the catalysis of the methylation from deoxyuridine monophosphate (dump) to deoxythymidine monophosphate. little is known about the significance of ts in bladder carcinoma. the authors investigated the activity of ts in 82 bladder cancers and prognostic significance of the levels of ts and/or activities of dihydropyrimidine dehydrogenase (dpd), an important enzyme in the degradation of 5-fu.
Methods:
The levels of ts and dpd activities in nonfixed, fresh, frozen, bladder carcinoma and normal bladder specimens were determined biochemically by the fdump binding assay and the 5-fu degradation assay, respectively.
Results:
The activity of ts was 10-fold higher in bladder carcinoma compared with normal bladder. ts activity in muscle-invasive bladder carcinoma was threefold higher than that in ta and t1 cancer. in addition, the activity of ts in t1 bladder carcinoma was threefold higher than that in ta cancer. the level of ts activity in grade 3 bladder carcinoma was 4.5-fold and 3.5-fold higher than that in grade 1 and grade 2 cancers, respectively. patients with ta and t1 bladder carcinoma with low ts activity had a longer postoperative tumor-free period than those with high activity in the 2-year follow-up. patients with ta and t1 bladder carcinoma with high or low ts activity were divided into four subgroups: high or low dpd activity subgroups. patients with low ts activity and high dpd activity had the longest postoperative disease-free period among the 4 subgroups during the 2-year follow-up.
Conclusions:
To the authors' knowledge, the current study is the first study that demonstrated that the level of ts activity correlates with both the progression of the stage and the increase of the grade of bladder carcinoma and that elevated ts activity predicts early recurrence in ta and t1 bladder carcinoma. these results suggested that elevated ts activity might have been associated with a higher chance of progression and recurrence of bladder carcinoma in the patients who participated in this study.
๐ SIMILAR VOLUMES
BACKGROUND. Before this study was conducted, the clinical and therapeutic significance of immunohistochemical evaluation of thymidylate synthase (TS) in patients with gastric carcinoma had not yet been clarified. ## METHODS. TS was immunohistochemically evaluated in 134 gastric carcinomas using a
Several recent studies have focused attention on neuroendocrine differentiation (NED) in prostatic carcinoma (PC). Clinical studies have shown PC with NED to behave aggressively and to be associated with poor prognosis. To evaluate NED as an independent prognostic factor, we conducted a retrospectiv